Skip to content
SearchSphereSource
Sign inSign up

apoplex medical technologies

The Deal

Bought By
Tobias Inderwies
Year
Not published by any primary source
One backer's card carries the company under its own 2024 entry year, which is that backer's date. The seller's annual report says it sold the company by a contract of September 17, 2024, and its announcement of November 5, 2024 says the sale to a German-American consortium concluded; neither names the buyer. The commercial register appoints him managing director on November 18, 2024. A trade site's 2025 table lists the company beside his vehicle, but its 2024 table omits the deal, which reads as a late report rather than a 2025 purchase. The year is inferred as 2024, and no page names the buyer with a date. No Form D names him.
Vehicle
Inderwies Unternehmensnachfolge, backed by Istria Capital and Relay Investments
Kind
Healthcare

A Pirmasens, Germany maker of automated ECG analysis software that detects signs of atrial fibrillation to flag stroke risk, used by more than two hundred clinics and by many German stroke units.

What Happened Next

Run by him as chief executive; both backers file it as active.

The exit ends of journeys like this one, where the buyer has announced the purchase itself, are on Buyers.

Backed by the Same Firms

Istria Capital

Relay Investments

Method & Source

This record is double-sourced: it joined when the purchase and, where the company has traded on, the exit could both be read in primary accounts rather than inferred.